Peakdale Molecular Reinforces its Commitment to Science and Extends its Discovery Park Lease
News Mar 02, 2016
Peakdale Molecular has extended its Discovery Park lease for a further ten years. The company, which is part of the Concept Life Sciences group, has been a tenant in Sandwich, Kent for six years and the lease renewal further signifies its commitment to the local area. Peakdale operates laboratory facilities at Discovery Park with the capacity for up to 50 chemists.
Commenting on the extension Paul Barber, Managing Director of Discovery Park said: “Peakdale Molecular has been present at Discovery Park since its launch in 2012, it was one of just five companies at the start and there are now over 125 companies. I am delighted that they have remained committed to Discovery Park and the facilities it offers.”
Peakdale’s Chief Operating Officer, Dr Paul Doyle added: “Discovery Park is one of Europe’s leading science and technology parks and home to a host of international companies. The Park is a vibrant hub of activity and offers the opportunity to share, engage and connect with other science based organisations; something we find incredibly valuable.
“Since the acquisition by Concept Life Sciences we have undergone a period of change which is set to transform into accelerated growth throughout 2016 and onwards. Securing a further 10-year tenancy at Discovery Park is testament to this growth period and indicates our ongoing commitment to our passionate and dedicated workforce.” In addition to the Sandwich site the company’s headquarters are located in the Peak District. Around 70 scientific staff are located here, with the capacity for 100 in total.
Michael Fort, Chairman of Concept Life Sciences, said: “The Discovery Park in Sandwich is a world renowned centre for science and technology and provides the perfect location for Peakdale which has over two decades of experience of supporting the pharmaceutical and biotech industries. Whilst Peakdale has its own positive reputation we have also found that being housed at Discovery Park also greatly assists with recruitment and we have been able to attract some of the brightest and best scientists to our team.”
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE